APO RESEARCH · REPORT
Taurine
Taurine is an organic acid widely distributed in animal tissues, and also exist in human beings’ body. But cats cannot produce taurine by itself.
Product & engineering
Understand the product.
Taurine is an organic acid widely distributed in animal tissues, and also exist in human beings’ body. But cats cannot produce taurine by itself.
Selected research
Market Structure
Global Taurine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Taurine is an organic acid widely distributed in animal tissues, and also exist in human beings’ body. But cats cannot produce taurine by itself.
Global Taurine key players include Yongan Pharmaceutical, Grand Pharma, Jiangyin Huachang, etc. Global top three manufacturers hold a share over 85%.
Asia-Pacific is the largest market, with a share over 30%, followed by Europe, and North America, both have a share over 55 percent.
Read the full market overview
In terms of product, Ethylene Oxide Method is the largest segment, with a share over 85%. And in terms of application, the largest application is Beverage, followed by Pet Food, Healthcare Products, etc.
This report provides an overview of the global Taurine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Taurine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Taurine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Taurine market size, projected growth trends, production technologies, key applications, and end-use industries.
Taurine Segment by Company
Yongan Pharmaceutical
Grand Pharma
Jiangyin Huachang
Yuanyang Pharmaceutical
Taisho Pharmaceutical
Taurine Segment by Technology
Ethylene Oxide Method
Ethanol Amine Method
Taurine Segment by Application
Beverage
Pet Food
Health Care Products
Others
Taurine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taurine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Taurine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taurine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Taurine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Taurine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Taurine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Taurine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Ethylene Oxide Method
- Ethanol Amine Method
Applications
- Beverage
- Pet Food
- Health Care Products
- Others
Companies covered
- Yongan Pharmaceutical
- Grand Pharma
- Jiangyin Huachang
- Yuanyang Pharmaceutical
- Taisho Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Taurine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Taurine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Taurine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Taurine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Taurine Market Dynamics
- 2.1 Taurine Industry Trends
- 2.2 Taurine Industry Drivers
- 2.3 Taurine Industry Opportunities and Challenges
- 2.4 Taurine Industry Restraints
3 Taurine Market by Manufacturers
- 3.1 Global Taurine Revenue by Manufacturers (2021-2026)
- 3.2 Global Taurine Sales by Manufacturers (2021-2026)
- 3.3 Global Taurine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Taurine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Taurine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Taurine Manufacturers, Product Type & Application
- 3.7 Global Taurine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Taurine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Taurine Players Market Share by Revenue in 2025
- 3.8.3 2025 Taurine Tier 1, Tier 2, and Tier 3
4 Taurine Market by Type
- 4.1 Taurine Type Introduction
- 4.1.1 Ethylene Oxide Method
- 4.1.2 Ethanol Amine Method
- 4.2 Global Taurine Sales by Type
- 4.2.1 Global Taurine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Taurine Sales by Type (2021-2032)
- 4.2.3 Global Taurine Sales Market Share by Type (2021-2032)
- 4.3 Global Taurine Revenue by Type
- 4.3.1 Global Taurine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Taurine Revenue by Type (2021-2032)
- 4.3.3 Global Taurine Revenue Market Share by Type (2021-2032)
5 Taurine Market by Application
- 5.1 Taurine Application Introduction
- 5.1.1 Beverage
- 5.1.2 Pet Food
- 5.1.3 Health Care Products
- 5.1.4 Others
- 5.2 Global Taurine Sales by Application
- 5.2.1 Global Taurine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Taurine Sales by Application (2021-2032)
- 5.2.3 Global Taurine Sales Market Share by Application (2021-2032)
- 5.3 Global Taurine Revenue by Application
- 5.3.1 Global Taurine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Taurine Revenue by Application (2021-2032)
- 5.3.3 Global Taurine Revenue Market Share by Application (2021-2032)
6 Global Taurine Sales by Region
- 6.1 Global Taurine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Taurine Sales by Region (2021-2032)
- 6.2.1 Global Taurine Sales by Region (2021-2026)
- 6.2.2 Global Taurine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Taurine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Taurine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Taurine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Taurine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Taurine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Taurine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Taurine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Taurine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Taurine Revenue by Region
- 7.1 Global Taurine Revenue by Region
- 7.1.1 Global Taurine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Taurine Revenue by Region (2021-2026)
- 7.1.3 Global Taurine Revenue by Region (2027-2032)
- 7.1.4 Global Taurine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Taurine Revenue (2021-2032)
- 7.2.2 North America Taurine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Taurine Revenue (2021-2032)
- 7.3.2 Europe Taurine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Taurine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Taurine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Taurine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Taurine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yongan Pharmaceutical
- 8.1.1 Yongan Pharmaceutical Company Information
- 8.1.2 Yongan Pharmaceutical Business Overview
- 8.1.3 Yongan Pharmaceutical Taurine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yongan Pharmaceutical Taurine Product Portfolio
- 8.1.5 Yongan Pharmaceutical Recent Developments
- 8.2 Grand Pharma
- 8.2.1 Grand Pharma Company Information
- 8.2.2 Grand Pharma Business Overview
- 8.2.3 Grand Pharma Taurine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Grand Pharma Taurine Product Portfolio
- 8.2.5 Grand Pharma Recent Developments
- 8.3 Jiangyin Huachang
- 8.3.1 Jiangyin Huachang Company Information
- 8.3.2 Jiangyin Huachang Business Overview
- 8.3.3 Jiangyin Huachang Taurine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jiangyin Huachang Taurine Product Portfolio
- 8.3.5 Jiangyin Huachang Recent Developments
- 8.4 Yuanyang Pharmaceutical
- 8.4.1 Yuanyang Pharmaceutical Company Information
- 8.4.2 Yuanyang Pharmaceutical Business Overview
- 8.4.3 Yuanyang Pharmaceutical Taurine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Yuanyang Pharmaceutical Taurine Product Portfolio
- 8.4.5 Yuanyang Pharmaceutical Recent Developments
- 8.5 Taisho Pharmaceutical
- 8.5.1 Taisho Pharmaceutical Company Information
- 8.5.2 Taisho Pharmaceutical Business Overview
- 8.5.3 Taisho Pharmaceutical Taurine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Taisho Pharmaceutical Taurine Product Portfolio
- 8.5.5 Taisho Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Taurine Value Chain Analysis
- 9.1.1 Taurine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Taurine Production Mode & Process
- 9.2 Taurine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Taurine Distributors
- 9.2.3 Taurine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst